New PreMiEr Publication: International Trial to Test Far-UVC Light as a Hospital Disinfection Tool
PreMiEr researchers are part of an international team launching a randomized controlled trial in Bolivia to evaluate whether Far-UVC light can safely and effectively reduce dangerous drug-resistant pathogens on hospital surfaces and in the air.
PreMiEr researchers are part of an international team launching a rigorous clinical trial to test whether Far-UVC light can meaningfully reduce dangerous drug-resistant pathogens in hospital settings. Far-UVC is an emerging disinfection technology that inactivates microorganisms but has limited penetration into human skin and eyes, making it potentially safe for continuous use in occupied spaces. The multi-site, double-blinded randomized controlled trial will be conducted in two hospitals in La Paz, Bolivia, targeting a group of particularly dangerous healthcare-associated pathogens known as ESKAPEE organisms. Hospital sinks will be assigned to either active Far-UVC lamps or identical sham lamps, with surface swabs, air samples, and chemical monitoring used to evaluate outcomes. The study protocol was published in 2026 and aims to generate real-world evidence on Far-UVC as a scalable infection control tool in low- and middle-income healthcare settings.
Read more here: https://doi.org/10.64898/2026.02.04.26345557